• MMED share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • Price change

    The price of MMED shares has decreased $0.08 since the market last closed. This is a 0.43% drop.

  • Opened at $18.38.

    The stock opened $0.02 lower than its previous close.

Key terms

About MMED

MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets, software platforms, and related accessories that help patients and healthcare providers effectively monitor and control blood glucose levels. The company was founded by Alfred E. Mann in 1983 and is headquartered in Northridge, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
  • Market cap: $5.17B

    A market capitalization between $2 billion and $10 billion places MMED in the mid-capitalization category.

Key terms

Smart score

Latest MMED news

Jul 28, 2026 8:21am ET MiniMed initiated with a Buy at UBS by TipRanks Jul 22, 2026 9:10am ET MiniMed announces Medicare beneficiaries have access to Flex system by TipRanks Jul 18, 2026 9:15pm ET Citi Sticks to Its Buy Rating for MiniMed Group, Inc. (MMED) by TipRanks Jul 15, 2026 3:25pm ET Analyst Reiterates Buy on MMED, Citing Strong Diabetes Tech Pipeline and Execution, With Price Target Unchanged at $20 by TipRanks Jul 14, 2026 7:10am ET Wall Street Analysts Are Bullish on Top NA Picks by TipRanks Jul 09, 2026 5:26am ET Citi Keeps Their Buy Rating on MiniMed Group, Inc. (MMED) by TipRanks Jun 29, 2026 9:10am ET MiniMed adds David Endicott, Linnea Burman to board of directors by TipRanks Jun 23, 2026 12:51pm ET MiniMed launches Instinct sensors in Europe by TipRanks Jun 17, 2026 9:45pm ET BTIG Remains a Buy on MiniMed Group, Inc. (MMED) by TipRanks Jun 09, 2026 5:15am ET Wells Fargo Reaffirms Their Buy Rating on MiniMed Group, Inc. (MMED) by TipRanks Jun 09, 2026 1:55am ET Analyst Reiterates Buy on MMED, Sees Favorable Risk/Reward with Unchanged $20 Price Target by TipRanks Jun 05, 2026 9:22am ET Evercore ISI Remains a Buy on MiniMed Group, Inc. (MMED) by TipRanks Jun 04, 2026 9:21am ET Analysts Offer Insights on NA Companies: MiniMed Group, Inc. (MMED) and Janus Living, Inc. Class A (JAN) by TipRanks Jun 04, 2026 9:05am ET Piper Sandler Reaffirms Their Hold Rating on MiniMed Group, Inc. (MMED) by TipRanks Jun 04, 2026 8:47am ET David Roman Lifts MiniMed Price Target to $24, Citing Strong Growth, Margin Outperformance and Compelling Valuation by TipRanks Jun 04, 2026 8:25am ET Benchmark Co. Reaffirms Their Buy Rating on MiniMed Group, Inc. (MMED) by TipRanks Jun 04, 2026 6:55am ET Bank of America Securities Sticks to Its Buy Rating for MiniMed Group, Inc. (MMED) by TipRanks Jun 04, 2026 6:50am ET Analysts Are Bullish on These NA Stocks: MiniMed Group, Inc. (MMED), Avalyn Pharma Inc (AVLN) by TipRanks Jun 04, 2026 6:37am ET MiniMed Group, Inc. (MMED) Gets a Buy from Wells Fargo by TipRanks Jun 04, 2026 6:36am ET MiniMed price target lowered to $22 from $26 at Wells Fargo by TipRanks Jun 04, 2026 6:36am ET Citi Remains a Buy on MiniMed Group, Inc. (MMED) by TipRanks Jun 04, 2026 6:35am ET MMED Buy Rating Reiterated as Analyst Sees Strong Fundamentals, FY27 Catalysts and Upside to Unchanged $25 Price Target by TipRanks Jun 03, 2026 7:49am ET MiniMed announces expanded ketone sensor agreement with Abbott by TipRanks Jun 03, 2026 6:55am ET MiniMed reports Q4 EPS (68c), consensus (22c) by TipRanks Jun 03, 2026 6:53am ET MiniMed sees FY27 organic revenue up 10% by TipRanks May 28, 2026 8:00am ET Citi Reaffirms Their Buy Rating on MiniMed Group, Inc. (MMED) by TipRanks May 18, 2026 8:07am ET MiniMed price target lowered to $20 from $27 at BofA by TipRanks May 12, 2026 3:09pm ET Toast downgraded, Lowe’s upgraded: Wall Street’s top analyst calls by TipRanks May 12, 2026 5:38am ET MiniMed initiated with a Buy at Benchmark by TipRanks May 11, 2026 4:50pm ET MiniMed initiated with a Buy at Benchmark by TipRanks May 06, 2026 5:16am ET MiniMed Group, Inc. (MMED) Gets a Buy from Evercore ISI by TipRanks
Apr 28, 2026 9:05am ET MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System by GlobeNewswire Apr 28, 2026 9:05am ET MiniMed annonce l’homologation par Santé Canada du capteur Simplera Sync🅪 et l’indication pour le diabète de type 2 avec le système MiniMed🅪 780G by GlobeNewswire

MMED Financials

1-year income & revenue

  • MMED total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • MMED net income: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • MMED earnings per share: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

MMED Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

MMED Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range
  • How competitors are chosen

    MMED's competitors are included in the Health Technology sector and Medical Specialties group

  • Market cap: $5.17B

    A market capitalization between $2 billion and $10 billion places MMED in the mid-capitalization category.

Key terms

Latest investing news